David Han, Ph.D., is Associate Professor of Cell Biology at the University of Connecticut Health Center. David is interested in utilizing proteomics and systems biology approaches to identify cancer biomarkers.
His group has developed a method, termed ‘Genomics-Driven Immunoproteomics' (GDI), which utilizes high-density peptide microarrays to identify breast cancer specific tumor antigens and antibodies that recognize these antigens. The eventual goal is to develop multi-targeted anti-cancer therapeutics using the GDI approach.
